Panagiotis Kottaridis

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

Panagiotis Kottaridis, Rosemary E. Gale, Marion E. Frew et al. · Blood · 2001 · 1.5K citations · Full text

Life Sciences, Genetics, Hematology +16

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

Panagiotis Kottaridis, Donald Milligan, Rajesh Chopra et al. · Blood · 2000 · 502 citations

Life Sciences, Cell Biology, Immunology +14

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

Suparno Chakrabarti, Stephen Mackinnon, Raj Chopra et al. · Blood · 2002 · 359 citations · Full text

Life Sciences, Hematology, Immunology +17

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

Ronjon Chakraverty, Karl S. Peggs, Rajesh Chopra et al. · Blood · 2002 · 344 citations · Full text

Medicine, Hematology, Immunology +16

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors

Panagiotis Kottaridis, Rosemary E. Gale, Stephen E. Langabeer et al. · Blood · 2002 · 307 citations · Full text

Medicine, Hematology, Molecular Genetics +17